Miragen Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $942k | 44k | 21.58 |
| 2025-06-30 | $610k | 44k | 13.98 |
| 2025-03-31 | $588k | 44k | 13.48 |
| 2024-12-31 | $849k | 44k | 19.17 |
| 2024-09-30 | $828k | 36k | 22.75 |
| 2024-06-30 | $473k | 36k | 13.01 |
| 2023-12-31 | $485k | 22k | 21.78 |
| 2023-09-30 | $342k | 22k | 15.34 |
| 2023-06-30 | $530k | 22k | 23.79 |
| 2023-03-31 | $505k | 20k | 25.44 |
| 2022-12-31 | $580k | 20k | 29.21 |
| 2022-09-30 | $281k | 14k | 20.49 |
| 2022-06-30 | $159k | 14k | 11.57 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors